Tigatuzumab
Based on 1 Customer Validation
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.
For research use only. We do not sell to patients.
- Purity : 98.18%
- CAS No.: 918127-53-4
- Molecular Weight:144.64 kDa
-
Storage:Shipping with dry ice
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
TNFRSF10B/TRAILR2/CD262
In Vitro
Tigatuzumab is sensitive to MIA PaCa-2 cells and BxPC-3 cells with IC50 values of 2.95 and 8.21 μg/mL, respectively[1]. Tigatuzumab (3-8 μg/mL; 5 h) induces apoptosis of cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MIA PaCa-2 and BxPC-3 cell lines
-
Concentration:3 and 8 μg/mL
-
Incubation Time:5 hours
-
Result:Induced cell apoptosis, and the methionine restriction increased the caspase activation and apoptosis in pancreatic cancer cells.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Nude mice with MIA PaCa-2-RFP human pancreatic cancer cells injection[1]
-
Dosage:3 mg/kg
-
Administration:Intravenous injection; 3 mg/kg weekly for 4 weeks
-
Result:Reduced the tumor volume and decreased the density of viable cancer cells in tumors.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | 2011-05 | PHASE1 |
Application
ELISA, FACS, Functional assay
Verified Bioactivity
-
Immobilized TRAIL R2/TNFRSF10B Protein, Human (HY-P72779) can bind Tigatuzumab. The EC50 for this effect is 4.074 ng/mL. -
Flow cytometric analysis of 1.5X106 HEPG2 cells with Tigatuzumab (HY-P99270, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa, Isotype Control (HY-P99001, blue) was used as the isotype control.
Product Details
-
CAS No. 918127-53-4
-
Accession O14763
-
Synonyms CS-1008; Anti-Human TRAIL-R2 Recombinant Antibody
-
Molecular Weight 144.64 kDa
-
Species Reactivity
Human
-
Conjugated
Unconjugated
-
Isotype
Human IgG1 kappa
-
Recommend Isotype Controls
-
Format
-
Human IgG1 kappa
-
Product Properties
-
Appearance
Liquid
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Purity
98.18%
-
Reconstitution
The product can be reconstituted/diluted with sterile PBS or saline.
-
Storage & Stability
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Shipping
Shipping with dry ice.
Purity & Documentation
References
Hot Topics
-
All
-
Topics
-
Most Recent
-
Oldest
-
Topics Dietary Protein Restriction & Aging
Dietary protein restriction (PR) is a nutritional intervention that reduces protein or specific amino acid intake without necessarily reducing total energy consumption.
2026-06-18
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)